Literature DB >> 959821

Cytoplasmic aldo-keto reductases: a class of drug metabolizing enzymes.

N R Bachur.   

Abstract

Aldehyde and ketone xenobiotic substances are preferentially reduced to alcohols by cytoplasmic enzymes in mammals. These enzymes are widely distributed in the tissues, have broad substrate specificities, have similar physical-chemical characteristics, and require reduced nicotinamide adenine dinucleotide as cofactor for the reductions. These reductases define a system of detoxification for aldehyde and ketone groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959821     DOI: 10.1126/science.959821

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Formation of pyridinium species of haloperidol in human liver and brain.

Authors:  D W Eyles; J J McGrath; S M Pond
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

3.  Metabolism of Monoterpenes: Conversion of l-Menthone to l-Menthol and d-Neomenthol by Stereospecific Dehydrogenases from Peppermint (Mentha piperita) Leaves.

Authors:  R Kjonaas; C Martinkus-Taylor; R Croteau
Journal:  Plant Physiol       Date:  1982-05       Impact factor: 8.340

4.  Integrated structural and evolutionary analysis reveals common mechanisms underlying adaptive evolution in mammals.

Authors:  Greg Slodkowicz; Nick Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

5.  Aldehyde reductase isozymes in the mouse: evidence for two new loci and localization of Ahr-3 on chromosome 7.

Authors:  P B Mather; R S Holmes
Journal:  Biochem Genet       Date:  1985-06       Impact factor: 1.890

6.  Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.

Authors:  H Iguchi; H Tone; T Ishikura; T Takeuchi; H Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.

Authors:  D W Eyles; H A Whiteford; T J Stedman; S M Pond
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Investigation of the arylnitroso reductase activity of pig liver aldehyde reductase.

Authors:  J Kovár; J Plocek
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

9.  Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.

Authors:  Srinivas M Tipparaju; Oleg A Barski; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

10.  Molecular cloning of cDNA for rat ovarian 20 alpha-hydroxysteroid dehydrogenase (HSD1).

Authors:  R Miura; K Shiota; K Noda; S Yagi; T Ogawa; M Takahashi
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.